Press Releases

Interim Financial Report as at 30 June 2021
24 September 2021
EN FR

Mithra Announces Topline Results for COVID-19 Phase II Study
24 September 2021
EN FR

Mithra Announces 2021 Half Year Results
24 September 2021
EN FR

Mithra Announces an Update on PeriNesta®
21 September 2021
EN FR

Donesta® Phase III: Recruitment Completion of American Study and Additional Recruitment in the European Study
21 September 2021
EN FR

Mithra to Host Webcast for Half Year Financial Results on 24 September 2021
17 September 2021
EN FR

Mithra Announces Estelle® Approval in Russia
16 September 2021
EN FR

Mithra and Searchlight Pharma Announce Availability of Nextstellis® in Pharmacies Across Canada
15 September 2021
EN FR

Mithra extends the pricing period for the put option announced on July 2, 2021 under the agreement with LDA Capital
13 August 2021
EN FR

ExeVir and Mithra announce manufacturing collaboration for innovative Covid-19 treatments
15 July 2021
EN FR

Mithra Issues a Put Option Notice Under Capital Agreement with LDA Capital
2 July 2021
EN FR

Mithra successfully renegotiates the earnouts relating to its Complex Therapeutics and acquires full licensing and distribution rights for Zoreline®
24 June 2021
EN FR